Sartorius Stedim Biotech

Equities

DIM

FR0013154002

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Paris Other stock markets 11:36:29 2024-05-10 am EDT			5-day change	1st Jan Change
205.7 ^EUR	-0.96%		-1.25%	-14.11%

Apr. 23	SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating	ZD
Apr. 22	Sartorius Stedim: in the red with brokerage comments	CF

Sartorius Stedim Biotech : Document AMF CP. 2023E938713

November 17, 2023 at 09:57 am EST

Date	Created	Title	Type	Company	Link
2023-11-17T00:00:00	2023-11-17T15:48:07.063	DeclarationPositionsCourtes	Document	CGG	Link
2023-11-17T00:00:00	2023-11-17T15:48:06.213	DeclarationPositionsCourtes	Document	AIR FRANCE-KLM	Link
2023-11-17T00:00:00	2023-11-17T15:48:05.357	DeclarationPositionsCourtes	Document	VALLOUREC	Link
2023-11-17T00:00:00	2023-11-17T15:48:04.29	DeclarationPositionsCourtes	Document	WENDEL	Link
2023-11-17T00:00:00	2023-11-17T15:48:03.44	DeclarationPositionsCourtes	Document	ELIOR GROUP	Link
2023-11-17T00:00:00	2023-11-17T15:46:06.917	DeclarationPositionsCourtes	Document	ATOS SE	Link
2023-11-17T00:00:00	2023-11-17T15:46:05.97	DeclarationPositionsCourtes	Document	SARTORIUS STEDIM BIOTECH	Link
2023-11-17T00:00:00	2023-11-17T15:46:05.15	DeclarationPositionsCourtes	Document	SOITEC	Link
2023-11-17T00:00:00	2023-11-17T15:46:04.33	DeclarationPositionsCourtes	Document	REXEL	Link
2023-11-17T00:00:00	2023-11-17T15:46:03.463	DeclarationPositionsCourtes	Document	ALSTOM	Link
2023-11-17T00:00:00	2023-11-17T15:44:08.15	DeclarationPositionsCourtes	Document	CGG	Link
2023-11-17T00:00:00	2023-11-17T15:44:07.3	DeclarationPositionsCourtes	Document	SOLUTIONS 30 SE	Link
2023-11-17T00:00:00	2023-11-17T15:44:06.5	DeclarationPositionsCourtes	Document	CELLECTIS	Link
2023-11-17T00:00:00	2023-11-17T15:44:05.71	DeclarationPositionsCourtes	Document	CELLECTIS	Link
2023-11-17T00:00:00	2023-11-17T15:42:05.573	DeclarationAchatVente	Document	ESI GROUP	Link
2023-11-17T00:00:00	2023-11-17T15:40:04.673	DeclarationAchatVente	Document	ESI GROUP	Link
2023-11-17T00:00:00	2023-11-17T14:26:03.5	ResultatOffre	Document	BALYO	Link
2023-11-17T00:00:00	2023-11-17T14:12:03.433	DeclarationAchatVente	Document	PCAS	Link
2023-11-17T00:00:00	2023-11-17T13:58:04.293	Declarations	Document	MERCIALYS	Link
2023-11-17T00:00:00	2023-11-17T13:58:03.393	DeclarationAchatVente	Document	OBER	Link
2023-11-17T00:00:00	2023-11-17T13:54:03.54	DeclarationAchatVente	Document	ESI GROUP	Link
null	2023-11-17T10:22:03.493	undefined	Communique	AGENCE FRANCE LOCALE	Link
null	2023-11-17T10:21:33.397	undefined	Communique	CAISSE FRANCAISE DE FINANCEMENT LOCAL	Link
null	2023-11-17T10:20:48.277	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
null	2023-11-17T10:20:45.65	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:20:42.303	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:20:39.5	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:26.247	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:22.43	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:19.47	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:16.27	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:12.397	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:15:24.517	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:15:21.483	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:15:18.14	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:15:14.947	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:12:03.807	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:11:48.96	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:08:47.727	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:06:51.17	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
null	2023-11-17T10:06:48.3	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
null	2023-11-17T10:06:45.577	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
null	2023-11-17T10:04:51.023	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
null	2023-11-17T10:04:48.31	undefined	Communique	NATIXIS	Link
null	2023-11-17T10:04:05.137	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
2023-11-16T00:00:00	2023-11-16T18:16:04.677	DeclarationDirigeants	Document	VETOQUINOL	Link
2023-11-16T00:00:00	2023-11-16T18:16:03.857	DeclarationDirigeants	Document	VETOQUINOL	Link
2023-11-16T00:00:00	2023-11-16T18:14:07.063	DeclarationDirigeants	Document	VISIOMED GROUP	Link
2023-11-16T00:00:00	2023-11-16T18:14:06.27	DeclarationDirigeants	Document	VISIOMED GROUP	Link
2023-11-16T00:00:00	2023-11-16T18:14:05.47	DeclarationDirigeants	Document	VISIOMED GROUP	Link
2023-11-16T00:00:00	2023-11-16T18:14:04.683	DeclarationDirigeants	Document	VISIOMED GROUP	Link
2023-11-16T00:00:00	2023-11-16T18:14:03.873	DeclarationDirigeants	Document	ARGAN	Link
2023-11-16T00:00:00	2023-11-16T18:12:07.887	DeclarationDirigeants	Document	VOGO	Link
2023-11-16T00:00:00	2023-11-16T18:12:07.093	DeclarationDirigeants	Document	GAUSSIN S.A.	Link
2023-11-16T00:00:00	2023-11-16T18:12:06.287	DeclarationDirigeants	Document	ARVERNE GROUP S.A.	Link
2023-11-16T00:00:00	2023-11-16T18:12:05.497	DeclarationDirigeants	Document	GAUSSIN S.A.	Link
2023-11-16T00:00:00	2023-11-16T18:12:04.683	DeclarationDirigeants	Document	GAUSSIN S.A.	Link
2023-11-16T00:00:00	2023-11-16T18:12:03.857	DeclarationDirigeants	Document	CYBERGUN	Link
2023-11-16T00:00:00	2023-11-16T18:10:07.317	DeclarationDirigeants	Document	PERNOD RICARD	Link
2023-11-16T00:00:00	2023-11-16T18:10:06.437	DeclarationDirigeants	Document	PERNOD RICARD	Link
2023-11-16T00:00:00	2023-11-16T18:10:05.56	DeclarationDirigeants	Document	PERNOD RICARD	Link
2023-11-16T00:00:00	2023-11-16T18:10:04.72	DeclarationDirigeants	Document	PERNOD RICARD	Link
2023-11-16T00:00:00	2023-11-16T18:10:03.847	DeclarationDirigeants	Document	PERNOD RICARD	Link
2023-11-16T00:00:00	2023-11-16T18:08:08.163	DeclarationDirigeants	Document	PERNOD RICARD	Link
2023-11-16T00:00:00	2023-11-16T18:08:07.323	DeclarationDirigeants	Document	PERNOD RICARD	Link
2023-11-16T00:00:00	2023-11-16T18:08:06.5	DeclarationDirigeants	Document	PERNOD RICARD	Link
2023-11-16T00:00:00	2023-11-16T18:08:05.663	DeclarationDirigeants	Document	VINCI	Link
2023-11-16T00:00:00	2023-11-16T18:08:04.79	DeclarationDirigeants	Document	BOUYGUES	Link
2023-11-16T00:00:00	2023-11-16T18:08:03.92	DeclarationDirigeants	Document	CRYPTO BLOCKCHAIN INDUSTRIES	Link
2023-11-16T00:00:00	2023-11-16T18:06:06.377	DeclarationDirigeants	Document	DASSAULT SYSTEMES	Link
2023-11-16T00:00:00	2023-11-16T18:06:05.53	DeclarationDirigeants	Document	RENAULT	Link
2023-11-16T00:00:00	2023-11-16T18:06:04.717	DeclarationDirigeants	Document	LVMH MOET HENNESSY-LOUIS VUITTON	Link
2023-11-16T00:00:00	2023-11-16T18:06:03.853	DeclarationDirigeants	Document	NEOEN	Link
2023-11-16T00:00:00	2023-11-16T17:54:03.877	DeclarationAchatVente	Document	ESI GROUP	Link
2023-11-16T00:00:00	2023-11-16T17:52:04.757	Declarations	Document	REXEL	Link
2023-11-16T00:00:00	2023-11-16T17:52:03.89	Declarations	Document	PUBLICIS GROUPE SA	Link
2023-11-16T00:00:00	2023-11-16T17:50:05.11	Declarations	Document	ESI GROUP	Link
2023-11-16T00:00:00	2023-11-16T17:50:03.87	DeclarationAchatVente	Document	ESI GROUP	Link
2023-11-16T00:00:00	2023-11-16T15:42:04.803	DeclarationPositionsCourtes	Document	CAPGEMINI	Link
2023-11-16T00:00:00	2023-11-16T15:42:03.907	DeclarationPositionsCourtes	Document	ALSTOM	Link
2023-11-16T00:00:00	2023-11-16T15:40:07.387	DeclarationPositionsCourtes	Document	AIR FRANCE-KLM	Link
2023-11-16T00:00:00	2023-11-16T15:40:06.537	DeclarationPositionsCourtes	Document	EUROAPI	Link
2023-11-16T00:00:00	2023-11-16T15:40:05.71	DeclarationPositionsCourtes	Document	REXEL	Link
2023-11-16T00:00:00	2023-11-16T15:40:04.833	DeclarationPositionsCourtes	Document	ELIOR GROUP	Link
2023-11-16T00:00:00	2023-11-16T15:40:03.953	DeclarationPositionsCourtes	Document	ALSTOM	Link
2023-11-16T00:00:00	2023-11-16T15:38:07.513	DeclarationPositionsCourtes	Document	EUROFINS SCIENTIFIC SE	Link
2023-11-16T00:00:00	2023-11-16T15:38:06.587	DeclarationPositionsCourtes	Document	CLARIANE SE	Link
2023-11-16T00:00:00	2023-11-16T15:38:05.683	DeclarationPositionsCourtes	Document	REXEL	Link
2023-11-16T00:00:00	2023-11-16T15:38:04.817	DeclarationPositionsCourtes	Document	AIR FRANCE-KLM	Link
2023-11-16T00:00:00	2023-11-16T15:36:07.753	DeclarationPositionsCourtes	Document	SOLUTIONS 30 SE	Link
2023-11-16T00:00:00	2023-11-16T15:36:06.767	DeclarationPositionsCourtes	Document	ATOS SE	Link
2023-11-16T00:00:00	2023-11-16T15:36:05.903	DeclarationPositionsCourtes	Document	CGG	Link
2023-11-16T00:00:00	2023-11-16T15:36:04.897	DeclarationPositionsCourtes	Document	ALSTOM	Link
2023-11-16T00:00:00	2023-11-16T15:36:03.973	DeclarationPositionsCourtes	Document	ALSTOM	Link
2023-11-16T00:00:00	2023-11-16T15:34:08.387	DeclarationPositionsCourtes	Document	VALEO	Link
2023-11-16T00:00:00	2023-11-16T15:34:07.39	DeclarationPositionsCourtes	Document	CELLECTIS	Link
2023-11-16T00:00:00	2023-11-16T13:40:03.89	DeclarationAchatVente	Document	ESI GROUP	Link
null	2023-11-16T13:34:05.48	Prospectus	Approbation	L'OREAL	Link
2023-11-16T00:00:00	2023-11-16T11:36:03.953	Declarations	Document	ERAMET	Link
2023-11-16T00:00:00	2023-11-16T11:12:03.873	DeclarationAchatVente	Document	PCAS	Link

Attachments

Original Link
Original Document
Permalink

Disclaimer

Sartorius Stedim Biotech SA published this content on 17 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 November 2023 14:56:24 UTC.

Latest news about Sartorius Stedim Biotech

SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating	Apr. 23	ZD
Sartorius Stedim: in the red with brokerage comments	Apr. 22	CF
UBS Cuts Sartorius Stedim Biotech PT, Maintains at Neutral	Apr. 22	MT
SARTORIUS STEDIM BIOTECH : Q1 24: A few positives despite the top-line miss	Apr. 22
SARTORIUS STEDIM : UBS reduces target price	Apr. 22	CF
Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	Apr. 18
Transcript : Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024	Apr. 18
Transcript : Sartorius Aktiengesellschaft, Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024	Apr. 18
Sartorius and subsidiary Stedim under pressure after weak figures	Apr. 18	DP
U.S. Futures, European Stocks Rise	Apr. 18	DJ
Sartorius Stedim: Quarterly EPS more than halved	Apr. 18	CF
Sartorius Stedim Biotech S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 18	CI
Sartorius Stedim Biotech Records Lower Q1 Attributable Net Profit, Sales Revenue	Apr. 18	MT
Transcript : Sartorius Stedim Biotech S.A. - Shareholder/Analyst Call	Mar. 26
SARTORIUS STEDIM BIOTECH : Jefferies remains its Buy rating	Mar. 12	ZD
Berenberg: Sartorius Stedim Investors Await 'Several Strong Quarters' for Confidence Boost	Feb. 16	MT
Sartorius gains despite halving dividend	Feb. 09	DP
Sartorius Stedim Biotech S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
Sartorius Stedim: dividend set for 2023	Feb. 08	CF
Dpa-AFX Overview: COMPANIES from 07.02.2024 - 15:15	Feb. 07	DP
Debt reduction: Sartorius sells shares - Stedim with capital increase	Feb. 07	DP
Sartorius Stedim Biotech Shares Fall After Capital Increase	Feb. 07	DJ
Sartorius Stedim Biotech Completes $1.3 Billion Capital Increase	Feb. 07	DJ
Sartorius Stedim: private placement of 5.15 million shares	Feb. 07	CF
Germany's Sartorius Raises EUR200 Million Via Share Issue	Feb. 07	MT

Chart Sartorius Stedim Biotech

Duration

Period

More charts

Company Profile

Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-16 - Capital Markets Day

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

SARTORIUS STEDIM BIOTECH : Q1 24: A few positives despite the top-line miss

April 22, 2024 at 07:56 am EDT

More Strategies

Ratings for Sartorius Stedim Biotech

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

205.7 EUR

Average target price

251.3 EUR

Spread / Average Target

+22.18%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SARTORIUS STEDIM BIOTECH	-14.11%	21.56B
ABBOTT LABORATORIES	-4.84%	182B
MEDTRONIC PLC	+0.56%	110B
BECTON, DICKINSON AND COMPANY	-3.35%	68.11B
DEXCOM, INC.	+2.39%	50.53B
CENCORA, INC.	+9.36%	44.8B
HOYA CORPORATION	+2.70%	40.7B
WEST PHARMACEUTICAL SERVICES, INC.	+3.43%	26.53B
TERUMO CORPORATION	+13.67%	25.02B
ZIMMER BIOMET HOLDINGS, INC.	-0.32%	24.96B

Other Medical Equipment, Supplies & Distribution